Integrated multiplatform method for in vitro quantitative assessment of cellular uptake for fluorescent polymer nanoparticles
2014-01-01 Ferrari, R; Lupi, M; Falcetta, F; Bigini, P; Paolella, K; Fiordaliso, F; Bisighini, C; Salmona, M; D'Incalci, M; Morbidelli, M; Moscatelli, D; Ubezio, P
Targeting G-Quadruplex DNA Structures by EMICORON Has a Strong Antitumor Efficacy against Advanced Models of Human Colon Cancer
2015-01-01 Porru, M; Artuso, S; Salvati, E; Bianco, A; Franceschin, M; Diodoro, Mg; Passeri, D; Orlandi, A; Savorani, F; D'Incalci, M; Biroccio, A; Leonetti, C
Mechanism of action of trabectedin in desmoplastic small round cell tumor cells
2017-01-01 Uboldi, S; Craparotta, I; Colella, G; Ronchetti, E; Beltrame, L; Vicario, S; Marchini, S; Panini, N; Dagrada, G; Bozzi, F; Pilotti, S; Galmarini, Cm; D'Incalci, M; Gatta, R
Quantification of trabectedin in human plasma: Validation of a high-performance liquid chromatography-mass spectrometry method and its application in a clinical pharmacokinetic study
2014-01-01 Zangarini, M; Ceriani, L; Sala, F; Marangon, E; Bagnati, R; D'Incalci, M; Grosso, F; Zucchetti, M
Hematotoxicity on human bone marrow- and umbilical cord blood-derived progenitor cells and in vitro therapeutic index of methoxymorpholinyldoxorubicin and its metabolites
1998-01-01 Ghielmini, M; Colli, E; Bosshard, G; Pennella, G; Geroni, C; Torri, V; D'Incalci, M; Cavalli, F; Sessa, C
Long-term benefit from trabectedin (T) in myxoid liposarcoma (MLS) patients
2008-01-01 Grosso, F; Sanfilippo, Rg; Dileo, P; Morosi, C; Virdis, E; Gronchi, A; Jimeno, J; Pilotti, S; D'Incalci, M; Casali, Pg
Editorial comment on "In vitro toxicity of ET-743 and Aplidine, two marine-derived antineoplastics, on human bone marrow haematopoietic progenitors: comparison with the clinical results" by Albella and colleagues
2002-01-01 D'Incalci, M
IDN 5390: an oral taxane candidate for protracted treatment schedules
2003-01-01 Pratesi, G; Laccabue, D; Lanzi, C; Cassinelli, G; Supino, R; Zucchetti, M; Frapolli, R; D'Incalci, M; Bombardelli, E; Morazzoni, P; Riva, A; Zunino, F
A prognostic regulatory pathway in stage I epithelial ovarian cancer: new hints for the poor prognosis assessment
2016-01-01 Calura, E; Paracchini, L; Fruscio, R; Difeo, A; Ravaggi, A; Peronne, J; Martini, P; Sales, G; Beltrame, L; Bignotti, E; Tognon, G; Milani, R; Clivio, L; Dell'Anna, T; Cattoretti, G; Katsaros, D; Sartori, E; Mangioni, C; Ardighieri, L; D'Incalci, M; Marchini, S; Romualdi, C
Chemotherapeutic activity of silymarin combined with doxorubicin or paclitaxel in sensitive and multidrug-resistant colon cancer cells
2011-01-01 Colombo, V; Lupi, M; Falcetta, F; Forestieri, D; D'Incalci, M; Ubezio, P
Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study
2007-01-01 Grosso, F; Jones, Rl; Demetri, Gd; Judson, Ir; Blay, Jy; Le Cesne, A; Sanfilippo, R; Casieri, P; Collini, P; Dileo, P; Spreafico, C; Stacchiotti, S; Tamborini, E; Tercero, Jc; Jimeno, J; D'Incalci, M; Gronchi, A; Fletcher, Ja; Pilotti, S; Casali, Pg
Analysis of aplidine (dehydrodidemnin B), a new marine-derived depsipeptide, in rat biological fluids by liquid chromatography-tandem mass spectrometry
1999-01-01 Celli, N; Gallardo, Am; Rossi, C; Zucchetti, M; D'Incalci, M; Rotilio, D
Sensitivity of CHO mutant cell lines with specific defects in nucleotide excision repair to different anti-cancer agents
1996-01-01 Damia, G; Imperatori, L; Stefanini, M; D'Incalci, M
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR THE DETERMINATION OF THE NOVEL ETOPOSIDE DERIVATIVE DIMETHYLAMINOETOPOSIDE (NK611) AND ITS METABOLITES IN URINE OF CANCER-PATIENTS
1995-01-01 Defusco, M; D'Incalci, M; Gentili, D; Reichert, S; Zucchetti, M
Cisplatinum and taxol induce different patterns of p53 phosphorylation
2001-01-01 Damia, G; Filiberti, L; Vikhanskaya, F; Carrassa, L; Taya, Y; D'Incalci, M; Broggini, M
Aplidine-induced apoptosis in MOLT-4 cells is mediated by its ability to block VEGF secretion
2001-01-01 Broggini, M; Marchini, S; Galliera, E; D'Incalci, M; Taraboletti, G; Giavazzi, R; Faircloth, Gt; Jimeno, J
"The Art of Successful Publication" ECCO 13 workshop report
2006-01-01 Smyth, J; Verweij, J; D'Incalci, M; Balakrishnan, L
Distribution and activity of doxorubicin combined with SDZ PSC 833 in mice with P388 and P388/DOX leukaemia
1996-01-01 Colombo, T; Paz, Og; D'Incalci, M
Dietary agent indole-3-carbinol protects female rats against the hepatotoxicity of the antitumor drug ET-743 (trabectidin) without compromising efficacy in a rat mammary carcinoma
2004-01-01 Donald, S; Verschoyle, Rd; Greaves, P; Colombo, T; Zucchetti, M; Falcioni, C; Zaffaroni, M; D'Incalci, M; Manson, Mm; Jimeno, J; Steward, Wp; Gescher, Aj
Non conventional suboptimal doses of gemcitabine (G) at fixed dose rate (FOR) infusion, combined with cisplatin (C), in patients with advanced non-small cell lung cancer (NSCLC)
2004-01-01 Caffo, O; Santo, A; Binato, S; Zucchetti, M; Lucenti, A; Centonze, M; Giovannini, M; D'Incalci, M; Cartei, G; Galligioni, E
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Integrated multiplatform method for in vitro quantitative assessment of cellular uptake for fluorescent polymer nanoparticles | 1-gen-2014 | Ferrari, R; Lupi, M; Falcetta, F; Bigini, P; Paolella, K; Fiordaliso, F; Bisighini, C; Salmona, M; D'Incalci, M; Morbidelli, M; Moscatelli, D; Ubezio, P | |
| Targeting G-Quadruplex DNA Structures by EMICORON Has a Strong Antitumor Efficacy against Advanced Models of Human Colon Cancer | 1-gen-2015 | Porru, M; Artuso, S; Salvati, E; Bianco, A; Franceschin, M; Diodoro, Mg; Passeri, D; Orlandi, A; Savorani, F; D'Incalci, M; Biroccio, A; Leonetti, C | |
| Mechanism of action of trabectedin in desmoplastic small round cell tumor cells | 1-gen-2017 | Uboldi, S; Craparotta, I; Colella, G; Ronchetti, E; Beltrame, L; Vicario, S; Marchini, S; Panini, N; Dagrada, G; Bozzi, F; Pilotti, S; Galmarini, Cm; D'Incalci, M; Gatta, R | |
| Quantification of trabectedin in human plasma: Validation of a high-performance liquid chromatography-mass spectrometry method and its application in a clinical pharmacokinetic study | 1-gen-2014 | Zangarini, M; Ceriani, L; Sala, F; Marangon, E; Bagnati, R; D'Incalci, M; Grosso, F; Zucchetti, M | |
| Hematotoxicity on human bone marrow- and umbilical cord blood-derived progenitor cells and in vitro therapeutic index of methoxymorpholinyldoxorubicin and its metabolites | 1-gen-1998 | Ghielmini, M; Colli, E; Bosshard, G; Pennella, G; Geroni, C; Torri, V; D'Incalci, M; Cavalli, F; Sessa, C | |
| Long-term benefit from trabectedin (T) in myxoid liposarcoma (MLS) patients | 1-gen-2008 | Grosso, F; Sanfilippo, Rg; Dileo, P; Morosi, C; Virdis, E; Gronchi, A; Jimeno, J; Pilotti, S; D'Incalci, M; Casali, Pg | |
| Editorial comment on "In vitro toxicity of ET-743 and Aplidine, two marine-derived antineoplastics, on human bone marrow haematopoietic progenitors: comparison with the clinical results" by Albella and colleagues | 1-gen-2002 | D'Incalci, M | |
| IDN 5390: an oral taxane candidate for protracted treatment schedules | 1-gen-2003 | Pratesi, G; Laccabue, D; Lanzi, C; Cassinelli, G; Supino, R; Zucchetti, M; Frapolli, R; D'Incalci, M; Bombardelli, E; Morazzoni, P; Riva, A; Zunino, F | |
| A prognostic regulatory pathway in stage I epithelial ovarian cancer: new hints for the poor prognosis assessment | 1-gen-2016 | Calura, E; Paracchini, L; Fruscio, R; Difeo, A; Ravaggi, A; Peronne, J; Martini, P; Sales, G; Beltrame, L; Bignotti, E; Tognon, G; Milani, R; Clivio, L; Dell'Anna, T; Cattoretti, G; Katsaros, D; Sartori, E; Mangioni, C; Ardighieri, L; D'Incalci, M; Marchini, S; Romualdi, C | |
| Chemotherapeutic activity of silymarin combined with doxorubicin or paclitaxel in sensitive and multidrug-resistant colon cancer cells | 1-gen-2011 | Colombo, V; Lupi, M; Falcetta, F; Forestieri, D; D'Incalci, M; Ubezio, P | |
| Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study | 1-gen-2007 | Grosso, F; Jones, Rl; Demetri, Gd; Judson, Ir; Blay, Jy; Le Cesne, A; Sanfilippo, R; Casieri, P; Collini, P; Dileo, P; Spreafico, C; Stacchiotti, S; Tamborini, E; Tercero, Jc; Jimeno, J; D'Incalci, M; Gronchi, A; Fletcher, Ja; Pilotti, S; Casali, Pg | |
| Analysis of aplidine (dehydrodidemnin B), a new marine-derived depsipeptide, in rat biological fluids by liquid chromatography-tandem mass spectrometry | 1-gen-1999 | Celli, N; Gallardo, Am; Rossi, C; Zucchetti, M; D'Incalci, M; Rotilio, D | |
| Sensitivity of CHO mutant cell lines with specific defects in nucleotide excision repair to different anti-cancer agents | 1-gen-1996 | Damia, G; Imperatori, L; Stefanini, M; D'Incalci, M | |
| HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR THE DETERMINATION OF THE NOVEL ETOPOSIDE DERIVATIVE DIMETHYLAMINOETOPOSIDE (NK611) AND ITS METABOLITES IN URINE OF CANCER-PATIENTS | 1-gen-1995 | Defusco, M; D'Incalci, M; Gentili, D; Reichert, S; Zucchetti, M | |
| Cisplatinum and taxol induce different patterns of p53 phosphorylation | 1-gen-2001 | Damia, G; Filiberti, L; Vikhanskaya, F; Carrassa, L; Taya, Y; D'Incalci, M; Broggini, M | |
| Aplidine-induced apoptosis in MOLT-4 cells is mediated by its ability to block VEGF secretion | 1-gen-2001 | Broggini, M; Marchini, S; Galliera, E; D'Incalci, M; Taraboletti, G; Giavazzi, R; Faircloth, Gt; Jimeno, J | |
| "The Art of Successful Publication" ECCO 13 workshop report | 1-gen-2006 | Smyth, J; Verweij, J; D'Incalci, M; Balakrishnan, L | |
| Distribution and activity of doxorubicin combined with SDZ PSC 833 in mice with P388 and P388/DOX leukaemia | 1-gen-1996 | Colombo, T; Paz, Og; D'Incalci, M | |
| Dietary agent indole-3-carbinol protects female rats against the hepatotoxicity of the antitumor drug ET-743 (trabectidin) without compromising efficacy in a rat mammary carcinoma | 1-gen-2004 | Donald, S; Verschoyle, Rd; Greaves, P; Colombo, T; Zucchetti, M; Falcioni, C; Zaffaroni, M; D'Incalci, M; Manson, Mm; Jimeno, J; Steward, Wp; Gescher, Aj | |
| Non conventional suboptimal doses of gemcitabine (G) at fixed dose rate (FOR) infusion, combined with cisplatin (C), in patients with advanced non-small cell lung cancer (NSCLC) | 1-gen-2004 | Caffo, O; Santo, A; Binato, S; Zucchetti, M; Lucenti, A; Centonze, M; Giovannini, M; D'Incalci, M; Cartei, G; Galligioni, E |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista26919
Data di pubblicazione
- In corso di stampa6
- 2020 - 20269123
- 2010 - 201911532
- 2000 - 20094500
- 1990 - 19991429
- 1980 - 1989306
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE368
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
- ANNALS OF ONCOLOGY243
- CANCERS228
- THE JOURNAL OF NUCLEAR MEDICINE220
- PLOS ONE212
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY193
- JOURNAL OF CLINICAL MEDICINE184
- ALLERGY180
Keyword
- Humans2101
- Female1005
- Male964
- Middle Aged745
- Aged643
- Adult550
- COVID-19415
- Treatment Outcome359
- Animals321
- Retrospective Studies262
Lingua
- eng19197
- ita408
- spa14
- fre11
- ger8
- enm3
- por2
- chi1
Accesso al fulltext
- no fulltext24666
- reserved1362
- open891